Rödl & Partner supports PharmaLex in merger with Regulis Consulting

PrintMailRate-it

Birmingham (United Kingdom), August 2020: Rödl & Partner advised the PharmaLex Group, a renowned consulting and services company, on its merger with Regulis Consulting Limited in the UK.

 

The merger with Regulis enables PharmaLex to further expand its services in the area of drug registration and safety. While the company operates internationally, it is committed to offering its broad portfolio at a local level. The strengthening of the existing UK team with experts in regulatory affairs, pharmacovigilance and quality assurance represents an important milestone in the company's regional presence. For Regulis, the merger opens up access to an international network of experts.

 

"The merger of PharmaLex and Regulis offers enormous potential for our complementary customer base and will further contribute to the successful development of our significant operations and business in the UK", said Jon Jeffery, Managing Director of PharmaLex UK.

 

Kim Wharton, Managing Director of Regulis, commented, “Our services in Regulatory Affairs, Pharmacovigilance and Quality Assurance align perfectly within the PharmaLex portfolio. Becoming part of a larger organisation with an excellent reputation and significant global footprint is an exciting step for Regulis.” PharmaLex was comprehensively advised on the transaction by a multidisciplinary cross-border M&A team from Rödl & Partner in Germany and the UK. Overall project management was provided by partners Jan Eberhardt and Jochen Reis. The advice focused on a complete legal, financial and tax due diligence as well as the contractual design of the purchase of Regulis shares.

  

About Regulis Consulting

Regulis Consulting is an independent pharmaceutical consultancy that offers expertise in the areas of Regulatory Affairs, Pharmacovigilance and Quality Assurance in the European and Global regulatory area. Regulis delivers customer focussed and compliant solutions, in what is a rapidly evolving and demanding regulatory environment.

  

About PharmaLex

PharmaLex is one of the world's leading service providers for development consulting, regulatory affairs, pharmacovigilance and quality management. For more than 25 years the company has been supporting its customers in all areas of drug approval and safety. Projects include the processing and takeover of complete drug dossiers as well as specific questions on a project basis. The PharmaLex Group employs an international team of over 1000 employees in 32 offices in 17 countries.


Advisers to PharmaLex

Rödl & Partner United Kingdom

Jan Eberhardt, Partner (Corporate/M&A), Birmingham, Overall Project Management - Legal
Charlotte Bateman, Senior Associate (Employment), Birmingham – Legal
Sumera Ehsan, Associate (Employment), Birmingham – Legal
Kiran Munawar, Associate (Corporate/M&A), Birmingham – Legal

  

Rödl & Partner Germany

Jochen Reis, Partner (Transaction Services), Eschborn, Overall Project Management – Financial
Florian Kaiser, Partner (Tax Law), Nuremberg – Tax
Dr. Patrick Satish, Associate Partner (Tax Law), Nuremberg – Tax
Felix Markowsky, Associate Partner (Transaction Services), Eschborn – Financial
Inga Heßdörfer, Senior Associate (Transaction Services), Eschborn – Financial
 

Advisers to Regulis

Wallace LLP

John Woodhouse, Partner (Corporate) – Legal
Sabrina Mitchell, Associate (Corporate) – Legal

Kontakt

Contact Person Picture

Jan Eberhardt

Partner

+44 121 2278 963
+44 121 2278 999

Send inquiry

We use cookies to personalise the website and offer you the greatest added value. They are, among other purposes, used to analyse visitor usage in order to improve the website for you. By using this website, you agree to their use. Further information can be found in our data privacy statement.
Deutschland Weltweit Search Menu